These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26657119)

  • 21. [G-protein-coupled receptors plasticity and signalling].
    Galés C
    Med Sci (Paris); 2012 Oct; 28(10):883-5. PubMed ID: 23067421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phytanic acid and pristanic acid, branched-chain fatty acids associated with Refsum disease and other inherited peroxisomal disorders, mediate intracellular Ca2+ signaling through activation of free fatty acid receptor GPR40.
    Kruska N; Reiser G
    Neurobiol Dis; 2011 Aug; 43(2):465-72. PubMed ID: 21570468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The changing world of G protein-coupled receptors.
    Fuxe K; Kenakin T
    J Recept Signal Transduct Res; 2010 Oct; 30(5):271. PubMed ID: 20858021
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of extended-release nicotinic acid on nonesterified fatty acid flux in the metabolic syndrome with atherogenic dyslipidemia.
    Vega GL; Cater NB; Meguro S; Grundy SM
    Am J Cardiol; 2005 Jun; 95(11):1309-13. PubMed ID: 15904634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [G-protein-coupled receptors, the beginning of a new era for therapeutic innovation].
    Bril A; Combettes M; Audinot V
    Med Sci (Paris); 2012 Oct; 28(10):799-800. PubMed ID: 23067404
    [No Abstract]   [Full Text] [Related]  

  • 26. Free Fatty Acid Receptors as new potential therapeutic target in inflammatory bowel diseases.
    Bartoszek A; Moo EV; Binienda A; Fabisiak A; Krajewska JB; Mosińska P; Niewinna K; Tarasiuk A; Martemyanov K; Salaga M; Fichna J
    Pharmacol Res; 2020 Feb; 152():104604. PubMed ID: 31846762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamics and flexibility of G-protein-coupled receptor conformations and their relevance to drug design.
    Vaidehi N
    Drug Discov Today; 2010 Nov; 15(21-22):951-7. PubMed ID: 20831898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Broad-spectrum amino acid-sensing class C G-protein coupled receptors: molecular mechanisms, physiological significance and options for drug development.
    Conigrave AD; Hampson DR
    Pharmacol Ther; 2010 Sep; 127(3):252-60. PubMed ID: 20451554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Switching modes for G protein-coupled receptor activation.
    Vilardaga JP
    Nat Chem Biol; 2006 Aug; 2(8):395-6. PubMed ID: 16850011
    [No Abstract]   [Full Text] [Related]  

  • 30. G protein-coupled receptors: abnormalities in signal transmission, disease states and pharmacotherapy.
    Zalewska M; Siara M; Sajewicz W
    Acta Pol Pharm; 2014; 71(2):229-43. PubMed ID: 25272642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diversifying the repertoire of G protein-coupled receptors through oligomerization.
    Park PS; Palczewski K
    Proc Natl Acad Sci U S A; 2005 Jun; 102(25):8793-4. PubMed ID: 15956197
    [No Abstract]   [Full Text] [Related]  

  • 32. Deorphanisation of G protein-coupled receptors: A tool to provide new insights in nervous system pathophysiology and new targets for psycho-active drugs.
    Lecca D; Abbracchio MP
    Neurochem Int; 2008 Feb; 52(3):339-51. PubMed ID: 17884255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model.
    Jensen MD
    Obesity (Silver Spring); 2006 Feb; 14 Suppl 1():20S-24S. PubMed ID: 16642959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dimerization of G protein-coupled receptors: molecular mechanism of the interprotomer communication].
    Yanagawa M; Shichida Y
    Seikagaku; 2011 Oct; 83(10):949-56. PubMed ID: 22184888
    [No Abstract]   [Full Text] [Related]  

  • 35. Minireview: The effects of species ortholog and SNP variation on receptors for free fatty acids.
    Hudson BD; Murdoch H; Milligan G
    Mol Endocrinol; 2013 Aug; 27(8):1177-87. PubMed ID: 23686113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of recombinant G-protein coupled receptors for structural biology.
    Mancia F; Hendrickson WA
    Mol Biosyst; 2007 Oct; 3(10):723-34. PubMed ID: 17882334
    [No Abstract]   [Full Text] [Related]  

  • 37. G protein-coupled receptors revisited: therapeutic applications inspired by synthetic biology.
    Heng BC; Aubel D; Fussenegger M
    Annu Rev Pharmacol Toxicol; 2014; 54():227-49. PubMed ID: 24160705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands.
    Festa C; Renga B; D'Amore C; Sepe V; Finamore C; De Marino S; Carino A; Cipriani S; Monti MC; Zampella A; Fiorucci S
    J Med Chem; 2014 Oct; 57(20):8477-95. PubMed ID: 25247751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addressing selective polypharmacology of antipsychotic drugs targeting the bioaminergic receptors through receptor dynamic conformational ensembles.
    Selvam B; Porter SL; Tikhonova IG
    J Chem Inf Model; 2013 Jul; 53(7):1761-74. PubMed ID: 23789628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Location and nature of the residues important for ligand recognition in G-protein coupled receptors.
    Bywater RP
    J Mol Recognit; 2005; 18(1):60-72. PubMed ID: 15386622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.